Vhl is commonly recognized as a tumor suppressor gene given that its homozygous deletion is known to induce tumors, particularly hemangioblastomas and renal cysts cancers, in a HIF-dependent fashion (see Haase, 2005; Kaelin, 2007 for reviews). The gene discussed is VHL; the disease is hemangioblastoma.